Rheumatology Doctors in Eldersburg, MD Accepting Medicare

3 Rheumatology doctors found. Showing 1 - 3

Florin Ioan Niculescu, M.D. PHD. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 6190 Georgetown Blvd, Suite 110, Eldersburg, MD 21784 Phone: 410-795-9700    Fax: 410-795-7500

Teodora M. Niculescu, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 6190 Georgetown Blvd, Suite 110, Eldersburg, MD 21784 Phone: 410-795-9700    Fax: 410-795-7500

Dr. Robert O'brian, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 6190 Georgetown Blvd, Suite 110, Eldersburg, MD 21784 Phone: 410-795-9700    Fax: 410-795-7500

News Archive

Researchers reveal how SMIP004 anticancer compound targets prostate cancer cells

One major hallmark of cancer cells is their ability to survive under stressful conditions. A new study spearheaded by researchers at Sanford-Burnham Medical Research Institute reveals how a promising anticancer compound called SMIP004 specifically kills prostate cancer cells by compromising their ability to withstand environmental stress.

Research shows potatoes can be part of weight loss regimen

Research just released by the University of California, Davis and the National Center for Food Safety and Technology, Illinois Institute of Technology demonstrates that people can include potatoes in their diet and still lose weight. This research was presented at the Obesity Society's 28th Annual Scientific Meeting October 8-12, 2010.

Enrollment complete in Idera's IMO-3100 Phase 2 trial for psoriasis

Idera Pharmaceuticals today announced that it had completed patient enrollment in its randomized, double-blind, placebo-controlled Phase 2 trial of IMO-3100 in patients with moderate-to-severe plaque psoriasis. IMO-3100 is an antagonist of specific Toll-like Receptors (TLRs) that the Company is developing for the treatment of psoriasis and other autoimmune diseases.

Full intensity heparin has value in treating hospitalized COVID-19 patients

Results from the RAPID clinical trial suggest heparin may lower the risk of death from moderate COVID-19 infection by 78%. Heparin also significantly increased the number of days patients went without ventilation or requiring organ support.

Read more Medical News

› Verified 3 days ago